Format

Send to

Choose Destination
See comment in PubMed Commons below
Support Care Cancer. 2006 Apr;14(4):348-53. Epub 2005 Oct 15.

An assessment of aetiology-based guidelines for the management of nausea and vomiting in patients with advanced cancer.

Author information

1
St. Luke's Hospice, Stamford Road, Turnchapel, Plymouth, PL9 9XA, UK. jeff.stephenson@stlukes-hospice.org.uk

Abstract

STUDY AIM:

The aim of this study was to assess the effectiveness of aetiology-based guidelines for the management of nausea and vomiting (N&V) in patients with advanced cancer.

PATIENTS AND METHODS:

This was a prospective study of 121 patients admitted to a hospice. Patients with N&V underwent assessments at presentation, 48 h and 1 week, to determine the aetiology of N&V and the response to treatment. Antiemetics were prescribed according to aetiology-based guidelines.

RESULTS:

Sixty-one patients (50%) had N&V during their admission: 21 (17%) had isolated nausea, 2 (2%) had isolated vomiting and 38 (31%) had combined N&V. During the assessment period, physicians altered their opinion about the primary cause of N&V in 26% of cases and finally expressed confidence about the aetiology in 75% of patients. The most common cause of N&V was impaired gastric emptying (contributing in 44% of patients), followed by chemical causes (33%) and bowel obstruction (19%). At 1 week, nausea was controlled in 56% of patients, and vomiting in 89% of patients, and residual symptoms were generally mild.

CONCLUSIONS:

An approach using aetiology-based guidelines in the management of N&V is moderately effective, although there are some patients with N&V refractory to standard antiemetic regimens.

PMID:
16228185
DOI:
10.1007/s00520-005-0897-1
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Springer
    Loading ...
    Support Center